A Silicon Valley Bank study recently looked at the behavior of private, venture capital-backed biotech and medical device companies in mergers and acquisitions. The study reviewed private merger or acquisition transactions by a selection of biotech and medical device companies. The conclusions about investments in life science companies surprised the bank because they ran counter […]
Read More...